Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
Chul Kyu RohYoun Young ChoiSeohee ChoiWon Jun SeoMinah ChoEunji JangTaeil SonHyoung Il KimHyeseon KimWoo Jin HyungYong Min HuhSung Hoon NohJae Ho CheongPublished in: Yonsei medical journal (2019)
SPC, MSI, and EBV statuses could be used in combination to predict the prognosis and responsiveness of adjuvant chemotherapy for stage II/III gastric cancer.